Академический Документы
Профессиональный Документы
Культура Документы
Bima Mandraguna
Betha Egih R
Teuku Aditya K
DEFINISI TRAUMA
Semua jenis kekerasan yang menimpa tubuh
sehingga terjadi kerusakan / gangguan pada
struktur dan fungsi jaringan / organ tubuh
yang terkena, bahkan secara sistemik dapat
berdampak pada aspek fisiologis, kejiwaan
dan kondisi sosial penderita yang
bersangkutan.
2
FAKTOR – FAKTOR
YANG BERPERAN
FAKTOR INTERNAL
- Keadaan Umum Penderita, Usia, Status Gizi
- Kondisi Premorbid penderita ( Kehamilan,
Penyakit lain, seperti Peny. Jantung,
Kelainan Ginjal, Kelainan Metabolik )
FAKTOR EKSTERNAL
- Jenis Trauma ( mempengaruhi perjalanan
penyakit dan prognosis, ada tidaknya cedera
inhalasi, shock, cedera penyerta lain )
- Penatalaksanaan ( Resusitasi, Rawat luka )
TRAUMA JARINGAN / ORGAN
KERUSAKAN
PERDARAHAN
NYERI
3
JENIS TRAUMA
• Ledakan benda berkecepatan tinggi, benda tajam
( tusukan, irisan, sabetan ), benda tumpul
• Suhu tinggi / rendah
uap panas
luka bakar
frostbite ( suhu dingin )
• Arus listrik tegangan tinggi
• Bahan kimia
• Radiasi, ionisasi
• Gigitan, sengatan
4
KERUSAKAN AKIBAT TRAUMA
BENTUK :
Diastase ( robekan ), memar, erosi, lecet, hancur ( crush injury ),
jaringan hilang
LOKALISASI :
• Jaringan lunak + kulit : - luka terbuka
- luka tertutup
5
6
7
9
16
AKIBAT TRAUMA
SEMBUH
CACAT
( anatomis + fisiologis + psikologis )
MENINGGAL
10
THE RESPONSE
Starts within minutes following the
traumatic impact
Characterized by the immediate activation
of monocytes and granulocytes
Leukocytic activation leads to an increased
synthesis and release of inflammatory and
anti-inflammatory mediators
Host Stress Response to Injury
Modulation by CNS
Afferent Arc Efferent Arc
Local Endocrine
Wound Response
Systemic Inflammation
Systemic Response
Demling et al. Surg Clin North Am 74(3); 1994.
Release of Mediators
“First Hit” POST INJURY “Second Hit”
Systemic Activation of
Inflammatory Cells
Primed
Lung Inflammatory
INITIAL INSULT Cells
Primed
Liver
Local Activation of Systemic Release WBCs
Inflammatory Cells of Cytokines Primed
Gut
WBCs
Other Primed
LOCAL
Organs WBCs
TISSUE
RESPONSE
SYSTEMIC RELEASE OF
TOXIC MEDIATORS
Demling et al. Surg Clin North Am 74(3); 1994.
GENERALIZED TISSUE INJURY
POST INJURY MULTIPLE
ORGAN FAILURE
MOF emerged as a clinical syndrome as a result of
our ability to keep pts alive with advanced technology
It remains the leading cause of late postinjury deaths
in the ICU
The association between the severity of MOF and
outcome is reflected in almost linear relationship
between the number of organs that have failed and
mortality
PREVENTION OF MOF
Prevention of MOF is a paramount importance
A common mistake is the believe that prevention of
MOF begins in the ICU
It does not . In the trauma pts, prevention begins in
the field, with rapid transportation to the hospital,
followed by the rapid institution of volume
resuscitation in the ED, meticulous assessment, early
and appropriate surgical intervention, through ICU
care and prompt reoperation when indicated
PREVENTABLE MISTAKES THAT CAN INCREASE
THE RISK OF MOF
1. Delays in diagnosis
2. Missed injuries
3. Inadequate and/or delayed volume resuscitation
4. Failure to recognize signs of inadequate tissue
perfusion
5. The use of antibiotics in place of adequate surgical
drainage and debridement
6. Delayed recognition of surgical misadventures
AMP
Ischemia
Adenosine
Xanthine dehydrogenase
Inosine
Xanthine oxidase
Hypoxanthine Xanthine
SOD Catalase
O2 O2- H2O2 H2O
Fe++
OH
Tissue
Reperfusion Damage
Severe SIRS
Early MOF
Moderate SIRS
First
Insult Moderate
2nd CARS
Severe
Insult
CARS
Host Factors
Shock
Tissue injury Infections Late MOF
Second Hits
SIRS : Systemic inflammatory response syndrome Moore & Moore : MODS following trauma, 2004
MOF : Multiple organ failure
CARS: Compensatory anti-inflammatory response syndrome
POST INJURY AUTOCANNIBALISM
CONTRIBUTES TO THE
PATHOGENESIS OF MOF
Musce Mass
Visceral protein
Organ function
Immune response
INFECTION
Shock
Resuscitation
Recovery
Recovery
1 3 10 14 21
Injury Days after injury
Normal radiograph
Dyspnea, tachypnea, normal chest examination
Mild pulmonary hypertension, normoxemic or mild
hypoxemia hypocarbia
Neutrophil sequestration, no clear tissue damage
Phase II (Onset of Parenchymal Changes)
Patchy alveolar infiltrates begining in dependent lung
Dyspnea, tachypnea, cyanosis, tachycardia, coarse rales
Pulmonary hypertension, normal wedge pressure,
increased lung permeability, increased lung increasing
shunt, progressive decrease in compliance, moderate-
to-serve hypoxemia
Neutrophil infiltration, vascular congestion, fibrin
strands, platelet clumps, alveolar septal edema,
intraalveolar protein, white cells, type 1 epithelial
damage
No perivascular cuffs (unless a component of water,
high-pressure edema is present)
Normal heart size
Phase 3 (Acute Respiratory Failure with Progression, 2-
10 Days)
Diffuse alveolar infiltrates
Tachypnea, tachycardia, hyperdynamic state, sepsis
syndrome, signs of consolidation, diffuse rhonchi
Phase 2 changes persist, progression of symptoms,
increasing shunt fraction, further decrease in compliance,
increased minute ventilation, impaired oxygen extraction of
hemoglobin
Increased interstitial and alveolar inflammatory exudate
with neutrophil and mononuclear cells, type II cell
proliferation, beginning fibroblast proliferation,
thromboembolic occlusion
Air bronchograms
Decreased lung volume
Normal heart size
Phase 4 (Pulmonary Fibrosis-Pneumonia with
Progression, >10 Days)b
Persistent diffuse infiltrates
Symptoms as above, recurrent sepsis, evidence of
multiple-system organ failure
Phase 3 changes persist, recurrent pneumonia,
progressive lung restriction, impaired tissue
oxygenation, impaired oxygen extraction,multiple-
system organ failure
Type II cell hyperplasia, interstitial thickening,
infiltration of lymphocytes, macrophages, fibroblasts,
loculated pneumonia and/or interstitial fibrosis, medial
thickening and remodeling of arterioles
Recurrent pneumothorax
Normal heart size , enlargement with pulmonale
therapy
Inhaled Nitric Oxide (pulmonary hypertension)
SURFACTANT REPLACEMENT THERAPY
CORTICOSTEROIDS
Thank you